The interaction of a series of spiropyrazolo[3,4-b]pyridines and spiropyrazolo[3,4-b]pyridine-5,5'-pyrimidines with 975 molecular targets involved in different diseases and biochemical alterations in humans was assessed. In-silico and in-vivo methods were used to predict the potential biological activity of these compounds. The exposure of several individuals of C. elegans to these compounds shows that their lethality would be less than 10% and that they do not induce any alteration in their locomotion. The compounds identified as PRV-8 and 13-G were the most bioactive, and also showed other advantages such as; better structural properties, adequate pharmacokinetic and pharmacodynamic properties, and good flexibility and unsaturation, which placed them as the compounds of greatest interest to be tested in-vitro and in-vivo. The series of compounds described here exhibited significant interactions with the estrogen signaling pathway.
Keywords: Drug design; Gaussian 09; KEGG Pathway; Molecular docking; Pyrazolopyridines; Pyrazolopyrimidines; String; Sybyl.
Copyright © 2020 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare no conflict of interest regarding any financial and personal relationships with other people or organizations that could inappropriately influence (bias) this work.
Synthesis of novel 7-aryl and 7-spiropyrazolo[4',3':5,6]pyrido[2,3-d]pyrimidine derivatives and their study as AChE inhibitors.Mol Divers. 2017 Nov;21(4):943-955. doi: 10.1007/s11030-017-9774-3. Epub 2017 Aug 7. Mol Divers. 2017. PMID: 28785929
Synthesis and mechanistic evaluation of novel N'-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents.Eur J Med Chem. 2017 Jul 28;135:213-229. doi: 10.1016/j.ejmech.2017.04.023. Epub 2017 Apr 14. Eur J Med Chem. 2017. PMID: 28453995
One-Pot Three-Component Synthesis and Molecular Docking of Some Novel 2-Thiazolyl Pyridines as Potent Antimicrobial Agents.Mini Rev Med Chem. 2019;19(6):527-538. doi: 10.2174/1389557518666181019124104. Mini Rev Med Chem. 2019. PMID: 30360710
Roles of Pyridine and Pyrimidine Derivatives as Privileged Scaffolds in Anticancer Agents.Mini Rev Med Chem. 2017;17(10):869-901. doi: 10.2174/1389557516666160923125801. Mini Rev Med Chem. 2017. PMID: 27670581 Review.
Understanding the challenges of protein flexibility in drug design.Expert Opin Drug Discov. 2015 Dec;10(12):1301-13. doi: 10.1517/17460441.2015.1094458. Epub 2015 Sep 28. Expert Opin Drug Discov. 2015. PMID: 26414598 Review.